Nasus Pharma stock reiterated at Market Outperform by Citizens
AI Summary
Citizens has reiterated its Market Outperform rating on Nasus Pharma stock. The article provides no further details on the rationale or any change to its price outlook.
Citizens has reiterated its Market Outperform rating on Nasus Pharma stock. The article provides no further details on the rationale or any change to its price outlook.
Punch Nigeria —
Punch Nigeria —
Le Monde —
Euronews —
Investing.com —
Offshore Engineer —